Cargando…

Safety and efficacy of ibrutinib in a patient with severe renal impairment

Detalles Bibliográficos
Autores principales: Filanovsky, Kalman, Shvidel, Lev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Scientific Publications, Pavia, Italy 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641823/
https://www.ncbi.nlm.nih.gov/pubmed/29071051
http://dx.doi.org/10.4081/hr.2017.7078
_version_ 1783271275012030464
author Filanovsky, Kalman
Shvidel, Lev
author_facet Filanovsky, Kalman
Shvidel, Lev
author_sort Filanovsky, Kalman
collection PubMed
description
format Online
Article
Text
id pubmed-5641823
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher PAGEPress Scientific Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-56418232017-10-25 Safety and efficacy of ibrutinib in a patient with severe renal impairment Filanovsky, Kalman Shvidel, Lev Hematol Rep Hematology Reports PAGEPress Scientific Publications, Pavia, Italy 2017-09-26 /pmc/articles/PMC5641823/ /pubmed/29071051 http://dx.doi.org/10.4081/hr.2017.7078 Text en ©Copyright A. Verentzioti et al., 2017 http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Hematology Reports
Filanovsky, Kalman
Shvidel, Lev
Safety and efficacy of ibrutinib in a patient with severe renal impairment
title Safety and efficacy of ibrutinib in a patient with severe renal impairment
title_full Safety and efficacy of ibrutinib in a patient with severe renal impairment
title_fullStr Safety and efficacy of ibrutinib in a patient with severe renal impairment
title_full_unstemmed Safety and efficacy of ibrutinib in a patient with severe renal impairment
title_short Safety and efficacy of ibrutinib in a patient with severe renal impairment
title_sort safety and efficacy of ibrutinib in a patient with severe renal impairment
topic Hematology Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641823/
https://www.ncbi.nlm.nih.gov/pubmed/29071051
http://dx.doi.org/10.4081/hr.2017.7078
work_keys_str_mv AT filanovskykalman safetyandefficacyofibrutinibinapatientwithsevererenalimpairment
AT shvidellev safetyandefficacyofibrutinibinapatientwithsevererenalimpairment